AREDS II supplementation is shown to slow progression in which AMD category?

Prepare for the NBEO Part III Test with comprehensive questions on Patient Encounters and Performance Skills. Answer multiple choice and scenario-based questions with explanations. Ensure success on your optometry exam!

Multiple Choice

AREDS II supplementation is shown to slow progression in which AMD category?

Explanation:
AREDS2 is aimed at people with moderate (intermediate) AMD in one or both eyes and looks at whether adding antioxidants and minerals can slow the eye’s progression to the advanced forms of AMD. The study found that this supplementation reduces the chance of progressing to advanced AMD (the neovascular or geographic atrophy forms) in those with moderate disease, helping to delay vision decline. It does not apply to early AMD, and once AMD is already in an advanced stage, this supplementation isn’t shown to reverse or substantially slow progression. So the best match is moderate AMD.

AREDS2 is aimed at people with moderate (intermediate) AMD in one or both eyes and looks at whether adding antioxidants and minerals can slow the eye’s progression to the advanced forms of AMD. The study found that this supplementation reduces the chance of progressing to advanced AMD (the neovascular or geographic atrophy forms) in those with moderate disease, helping to delay vision decline. It does not apply to early AMD, and once AMD is already in an advanced stage, this supplementation isn’t shown to reverse or substantially slow progression. So the best match is moderate AMD.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy